Workflow
Novo Nordisk(NVO)
icon
Search documents
X @Bloomberg
Bloomberg· 2025-07-29 16:24
Maziar Mike Doustdar spent over three decades quietly climbing the ranks of Novo. Now the relatively unknown insider is moving into the spotlight with the daunting task of reviving the drugmaker https://t.co/cRYdao1vvT ...
Don't buy the dip in Novo Nordisk yet, says Mizuho's Jared Holz
CNBC Television· 2025-07-29 15:47
Welcome back to Money Movers. Take a look at Novo today. Down double digits on pace for the worst day since 87 as the company cuts slashes really its fullear guidance.Novo saying that it now expects weaker growth expectations in the second half for GLP1 drugs WGOmpic. Company also announces the appointment of its incoming CEO Mike Dotstar effective August 7th. Joining us now to break down the move is Missouo healthcare equity strategist Jared Holtz.Jared, who writes, "Today, we believe analysts will start t ...
明晟公司MSCI北欧国家指数下跌4.3%,创4月4日(当天收跌6.4%)以来最差单日表现,报343.08点。10个板块中,北欧医疗保健板块表现最差。诺和诺德跌23.1%,领跌一众成分股。
news flash· 2025-07-29 15:44
Core Points - MSCI Nordic Countries Index declined by 4.3%, marking the worst single-day performance since April 4, when it fell by 6.4%, closing at 343.08 points [1] - Among the 10 sectors, the Nordic healthcare sector performed the worst [1] - Novo Nordisk dropped by 23.1%, leading the decline among constituent stocks [1]
Novo Nordisk sinks on guidance cut
CNBC Television· 2025-07-29 15:08
United Healthcare under pressure again after the company said 2025 earnings will be worse than expected, citing higher medical costs. That's been a theme with the insurers. And then Nova Nordic shares on pace for one of their worst days on record.Let's get to Angelica Peoples with the details on that name in particular. Angelica, it it doesn't come out of nowhere because the stock has been on a on a bumpy ride, but I guess it goes from bad to worse. >> Yeah, Sarah, it has definitely been a bumpy ride, but t ...
X @Forbes
Forbes· 2025-07-29 15:00
Novo Nordisk Shares Plunge 21% Toward Worst Day In 40 Years—As Ozempic Sales Expected To Slowhttps://t.co/CpHpqJlQWR https://t.co/c9tSYcZ33E ...
最新世界500强出炉:沃尔玛稳坐第一,还有这些最赚钱制药公司
第一财经· 2025-07-29 14:45
Core Insights - The total revenue of the 2025 Fortune Global 500 companies reached approximately $41.7 trillion, accounting for over one-third of the global GDP, with a year-on-year growth of about 1.8% [1] - The net profit of these companies increased by approximately 0.4% year-on-year, totaling around $2.98 trillion, marking the highest asset and net asset totals since the inception of the Fortune Global 500 list [1] Group 1: Top Companies - Walmart has maintained its position as the largest company globally for the twelfth consecutive year, followed by Amazon, State Grid Corporation of China, Saudi Aramco, and China National Petroleum [3] - Walmart's first-quarter revenue for the period ending April 30, 2025, was $165.6 billion, a 2.5% increase from $161.5 billion in the same period last year, with a net sales figure of $164 billion [4] Group 2: Energy Sector - State Grid Corporation of China ranked third in the Fortune Global 500 for the second consecutive year, recognized for its leading technology in ultra-high voltage transmission and smart grid systems [6] - China Petroleum and Chemical Corporation ranked sixth, while Shandong Gold Group was the only new Chinese company to make the list, ranking 465th, benefiting from a significant increase in gold prices [6] Group 3: Pharmaceutical Companies - Among the 50 most profitable companies, three are pharmaceutical firms: Merck, Novo Nordisk, and Johnson & Johnson, with Merck's profit increasing significantly by 45.9 times due to the sales of its PD-1 product, Keytruda [8][9] - Novo Nordisk's profit grew by 20.6%, driven by the sales of its GLP-1 receptor agonist products, which reached $29.3 billion in 2024, a 38% increase [9][10] - The total number of pharmaceutical companies in the 2025 list increased to 15, with Amgen being the new entrant, while Guangzhou Pharmaceutical Group was the only Chinese pharmaceutical company included [11]
美股三大指数涨跌互现,纳指与标普再创历史新高,中概股多数下跌
中概股方面,搜狐、网易有道、微博涨超1%,金山云跌超7%,小马智行跌超6%,小鹏汽车、爱奇艺跌 超2%,蔚来、贝壳、高途、百度跌超1%。 凤凰网财经讯 7月29日,美股三大指数涨跌互现,纳指与标普再创历史新高。截至发稿,道指跌 0.06%,纳指涨0.18%,标普500指数涨0.12%。 个股方面,诺和诺德跌超21%,公司下调2025年展望;联合健康跌超5%,公司2025财年业绩指引低于 市场预期。 销售额同比增超两倍,Meta这款AI眼镜火了 新一代产品或9月亮相 诺和诺德股价暴跌 此前任命新首席执行官并下调全年业绩预期 全球要闻 全球的减肥药巨头,诺和诺德,刚刚股价崩盘了。丹麦制药巨头诺和诺德周二下调了全年销售额和利润 指引,理由是其明星减肥药Wegovy在美国这一关键市场的增长预期疲软。公司还宣布,内部候选人 Maziar Mike Doustdar将接替今年5月被意外撤换的Lars Fruergaard Jrgensen,出任新任首席执行官。 什么信号?美联储会议召开在即 华尔街对关税影响已不再那么担忧 随着上周末美国与欧盟达成贸易协议,现在看来,特朗普总统征收的实际关税税率,最终将在15%-20% 的 ...
诺和诺德候任CEO Mike Doustdar谈及股价急剧下跌: 股价下跌让新任CEO的责任变得更加沉重
Hua Er Jie Jian Wen· 2025-07-29 14:38
(文章来源:华尔街见闻) 诺和诺德候任CEO Mike Doustdar谈及(公司股票)价格急剧下跌,称:我不喜欢这样。 股价下跌让新任CEO的责任变得更加沉重。 ...
诺和诺德主席Helge Lund:候任CEO Doustdar对速度、幅度、行动有“自己的见解”
Hua Er Jie Jian Wen· 2025-07-29 14:22
诺和诺德主席Helge Lund:候任CEO Doustdar对速度、幅度、行动有"自己的见解"。 Doustdar知道公司的强项和弱项。 (文章来源:华尔街见闻) ...
诺和诺德(董事会)主席Helge Lund:候任CEO Doustdar对速度、幅度、行动有“自己的见解”。Doustdar知道公司的强项和弱项。
news flash· 2025-07-29 14:20
诺和诺德(董事会)主席Helge Lund:候任CEO Doustdar对速度、幅度、行动有"自己的见解"。 Doustdar知道公司的强项和弱项。 ...